Medtronic (MDT) Invested Capital (2013 - 2026)

Medtronic has disclosed Invested Capital across 14 years of filings, most recently posting $49.4 billion for Q1 2026.

• Invested Capital for Q1 2026 came in at $49.4 billion, down 5.46% year-over-year; the trailing twelve-month figure through Jan 2026 was $49.4 billion (down 5.46% YoY), and the FY2025 annual result was $51.1 billion, down 0.74% from the prior year.
• Invested Capital came in at $49.4 billion for Q1 2026 at Medtronic, down from $50.3 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $58.6 billion in Q3 2022 to a low of $49.4 billion in Q1 2026.
• The 5-year median for Invested Capital is $52.2 billion (2025), against an average of $53.0 billion.
• Across the five-year window, Invested Capital increased 13.36% in 2022 and slipped 11.42% in 2023, its largest moves.
• Medtronic's Invested Capital stood at $57.9 billion in 2022, then retreated by 8.52% to $53.0 billion in 2023, then fell by 1.04% to $52.4 billion in 2024, then retreated by 4.12% to $50.3 billion in 2025, then decreased by 1.77% to $49.4 billion in 2026.
• The last three Invested Capital figures came in at $49.4 billion (Q1 2026), $50.3 billion (Q4 2025), and $50.6 billion (Q3 2025), per Business Quant data.